StockTipsArenaBeta

BUY Mankind Pharma Limited — Nilesh Jain, Centrum Broking

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byNilesh Jain, Centrum BrokingHorizon: NA (inferred Swing (≤2wk))28 Jul 2026via CNBC Awaaz.

Entry₹2,587.1Inferred
Target₹2,700
Total upside +4.36% (call closed)
Stop loss₹2,550-1.43% risk
Exit₹2,55031 Jul 2026, 9:15 am
Stop-loss hit-1.43%
Follow Nilesh Jain for new calls(32% target hit, 138 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 31 Jul 2026
5 supporting1 neutral0 opposing
Supports the BUY call (5)

Mankind Pharma Q1 profit rises 30%, margins expand on strong domestic business

NewsCnbc-Tv18·30 Jul · today

(opens in new tab)

Mankind Pharma announced strong Q1FY27 financial results with a 13% YoY revenue growth to INR 4,031 Crore and a 25% YoY EBITDA growth to INR 1,060 Crore. PAT grew by 29% YoY. The company highlighted d

BSE · Company Update·30 Jul · today

(opens in new tab)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·29 Jul · 2d ago

Mankind Pharma completes sale of Broadway Hospitality stake for ₹49 crore

NewsGoogle News·27 Jul · 3d ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·7 Jul · 3w ago

Neutral / worth noting (1)

Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·30 Jul · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Nilesh Jain, Centrum Broking

Every call and its outcome